PMID- 21203348 OWN - NLM STAT- MEDLINE DCOM- 20110208 LR - 20220331 IS - 1090-0535 (Electronic) IS - 1090-0535 (Linking) VI - 16 DP - 2010 Dec 31 TI - Changes to tear cytokines of type 2 diabetic patients with or without retinopathy. PG - 2931-8 AB - PURPOSE: To investigate changes in cytokine levels in tears of type 2 diabetics with or without retinopathy. METHODS: Tears were collected from 15 type 2 diabetics without retinopathy (DNR), 15 patients with retinopathy (DR), and 15 age and gender matched non-diabetic controls. Tear concentrations of 27 cytokines were measured by multiplex bead immunoassay. Cytokine differences between groups, ratios of type-1 T helper (Th1)/type-2 T helper (Th2) cytokines and anti-angiogenic/pro-angiogenic cytokines were analyzed statistically. RESULTS: The most abundant cytokine detected in tears was interferon-induced protein-10 (IP-10). In comparison with controls, IP-10 and monocyte chemoattracant protein-1 (MCP-1) levels were significantly elevated in DR (p=0.016 and 0.036, respectively) and DNR groups (p=0.021 and 0.026, respectively). Interleukin-1 (IL-1) receptor antagonist (IL-1ra) levels were significantly increased in DNR (p=0.016). Th1/Th2 cytokines interferon-gamma (IFN-gamma)/IL-5 and IL-2/IL-5 ratios were significantly increased in DR compared to controls (p=0.037 and 0.031, respectively). Anti-angiogenic/angiogenic cytokines IFN-gamma/MCP-1 and IL-4/MCP-1 ratios in DR and DNR were significantly decreased compared to controls (p<0.05). IL-4/IL-8 and IL-12p70/IL-8 ratios were also significantly decreased in DR compared to controls (p=0.02 and 0.045, respectively). No significant correlation was demonstrated between tear cytokine concentrations and glycosylated hemoglobin (HbA1c) or fasting plasma glucose (FPG). CONCLUSIONS: Diabetic tears exhibited elevated levels of IP-10 and MCP-1. The Th1/Th2 cytokine balance may shift to a predominantly Th1 state in DR patients. Pro-angiogenic cytokines are more highly represented than anti-angiogenic cytokines in the tears of diabetic patients. FAU - Liu, Jingfang AU - Liu J AD - First Hospital Affiliated to Medical College, Xi'an Jiaotong University, Xi'an, China. FAU - Shi, Bingyin AU - Shi B FAU - He, Shuixiang AU - He S FAU - Yao, Xiaoli AU - Yao X FAU - Willcox, Mark D P AU - Willcox MD FAU - Zhao, Zhenjun AU - Zhao Z LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20101231 PL - United States TA - Mol Vis JT - Molecular vision JID - 9605351 RN - 0 (Angiogenesis Inducing Agents) RN - 0 (Angiogenesis Inhibitors) RN - 0 (Cytokines) RN - 0 (Immunoglobulin A) SB - IM MH - Angiogenesis Inducing Agents/metabolism MH - Angiogenesis Inhibitors/metabolism MH - Case-Control Studies MH - Cytokines/*metabolism MH - Diabetes Mellitus, Type 2/*complications/*immunology MH - Diabetic Retinopathy/*complications/*immunology MH - Female MH - Humans MH - Immunoglobulin A/metabolism MH - Male MH - Middle Aged MH - Phenotype MH - Tears/*immunology MH - Th1 Cells/metabolism MH - Th2 Cells/metabolism PMC - PMC3013072 EDAT- 2011/01/05 06:00 MHDA- 2011/02/09 06:00 PMCR- 2010/01/01 CRDT- 2011/01/05 06:00 PHST- 2010/08/31 00:00 [received] PHST- 2010/12/25 00:00 [accepted] PHST- 2011/01/05 06:00 [entrez] PHST- 2011/01/05 06:00 [pubmed] PHST- 2011/02/09 06:00 [medline] PHST- 2010/01/01 00:00 [pmc-release] AID - 315 [pii] AID - 2010MOLVIS0369 [pii] PST - epublish SO - Mol Vis. 2010 Dec 31;16:2931-8.